

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.87136678 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.04636999 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.04636999 |
| 4 | neutrophil activation involved in immune response (GO:0002283) | 4.87866192 |
| 5 | ribosomal small subunit assembly (GO:0000028) | 4.82463938 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.68936151 |
| 7 | definitive hemopoiesis (GO:0060216) | 4.50126606 |
| 8 | response to interferon-beta (GO:0035456) | 4.46192814 |
| 9 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.41169585 |
| 10 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.27156375 |
| 11 | response to peptidoglycan (GO:0032494) | 4.26770800 |
| 12 | response to interferon-alpha (GO:0035455) | 4.13576542 |
| 13 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.08383180 |
| 14 | NIK/NF-kappaB signaling (GO:0038061) | 4.04861180 |
| 15 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.01199894 |
| 16 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.97209565 |
| 17 | neutrophil activation (GO:0042119) | 3.87117332 |
| 18 | myeloid dendritic cell activation (GO:0001773) | 3.83163477 |
| 19 | barbed-end actin filament capping (GO:0051016) | 3.81366348 |
| 20 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.77707991 |
| 21 | myeloid dendritic cell differentiation (GO:0043011) | 3.73886482 |
| 22 | granulocyte activation (GO:0036230) | 3.73790675 |
| 23 | negative regulation of phagocytosis (GO:0050765) | 3.67980562 |
| 24 | platelet dense granule organization (GO:0060155) | 3.66174658 |
| 25 | negative regulation of viral genome replication (GO:0045071) | 3.63769433 |
| 26 | positive regulation of B cell differentiation (GO:0045579) | 3.63064798 |
| 27 | defense response to protozoan (GO:0042832) | 3.58277596 |
| 28 | response to muramyl dipeptide (GO:0032495) | 3.55207009 |
| 29 | endothelium development (GO:0003158) | 3.49084149 |
| 30 | respiratory burst (GO:0045730) | 3.49045924 |
| 31 | type I interferon signaling pathway (GO:0060337) | 3.46449412 |
| 32 | cellular response to type I interferon (GO:0071357) | 3.46449412 |
| 33 | response to type I interferon (GO:0034340) | 3.45144027 |
| 34 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.44734660 |
| 35 | modulation by symbiont of host immune response (GO:0052553) | 3.44734660 |
| 36 | positive regulation by symbiont of host defense response (GO:0052509) | 3.44734660 |
| 37 | modulation by symbiont of host defense response (GO:0052031) | 3.44734660 |
| 38 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.44734660 |
| 39 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.44734660 |
| 40 | immunoglobulin mediated immune response (GO:0016064) | 3.43821657 |
| 41 | response to protozoan (GO:0001562) | 3.39631697 |
| 42 | neutrophil mediated immunity (GO:0002446) | 3.37805694 |
| 43 | regulation of natural killer cell differentiation (GO:0032823) | 3.34098746 |
| 44 | stress fiber assembly (GO:0043149) | 3.31713655 |
| 45 | positive regulation of antigen processing and presentation (GO:0002579) | 3.30266332 |
| 46 | dendritic cell differentiation (GO:0097028) | 3.28562695 |
| 47 | myeloid cell activation involved in immune response (GO:0002275) | 3.27332773 |
| 48 | T-helper 1 type immune response (GO:0042088) | 3.23879025 |
| 49 | necroptotic process (GO:0070266) | 3.21678923 |
| 50 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.20627355 |
| 51 | actin nucleation (GO:0045010) | 3.19268475 |
| 52 | regulation of necroptotic process (GO:0060544) | 3.17832147 |
| 53 | postsynaptic membrane organization (GO:0001941) | 3.17713816 |
| 54 | endosome to melanosome transport (GO:0035646) | 3.16088015 |
| 55 | endosome to pigment granule transport (GO:0043485) | 3.16088015 |
| 56 | regulation of RIG-I signaling pathway (GO:0039535) | 3.09039771 |
| 57 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.08481429 |
| 58 | secretory granule organization (GO:0033363) | 3.07354989 |
| 59 | response to fungus (GO:0009620) | 3.05472108 |
| 60 | megakaryocyte development (GO:0035855) | 3.05307173 |
| 61 | positive regulation of natural killer cell activation (GO:0032816) | 3.03942041 |
| 62 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.03071169 |
| 63 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.03017724 |
| 64 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.02123812 |
| 65 | adenosine receptor signaling pathway (GO:0001973) | 3.00601162 |
| 66 | mast cell activation (GO:0045576) | 2.99141602 |
| 67 | regulation of necrotic cell death (GO:0010939) | 2.98807003 |
| 68 | positive regulation of macrophage differentiation (GO:0045651) | 2.98391180 |
| 69 | myeloid leukocyte mediated immunity (GO:0002444) | 2.97860750 |
| 70 | leukocyte degranulation (GO:0043299) | 2.97163412 |
| 71 | positive regulation of interferon-alpha production (GO:0032727) | 2.94725450 |
| 72 | execution phase of apoptosis (GO:0097194) | 2.94386184 |
| 73 | regulation of antigen processing and presentation (GO:0002577) | 2.94118317 |
| 74 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.92103302 |
| 75 | cellular response to interferon-beta (GO:0035458) | 2.92073540 |
| 76 | negative regulation of interleukin-17 production (GO:0032700) | 2.92056694 |
| 77 | mature B cell differentiation involved in immune response (GO:0002313) | 2.90166829 |
| 78 | angiogenesis involved in wound healing (GO:0060055) | 2.89818546 |
| 79 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.86072252 |
| 80 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.86030727 |
| 81 | response to host immune response (GO:0052572) | 2.85907602 |
| 82 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.85907602 |
| 83 | leukocyte mediated cytotoxicity (GO:0001909) | 2.85864170 |
| 84 | regulation of erythrocyte differentiation (GO:0045646) | 2.85484163 |
| 85 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 2.84772593 |
| 86 | B cell mediated immunity (GO:0019724) | 2.84569249 |
| 87 | macrophage activation involved in immune response (GO:0002281) | 2.84240424 |
| 88 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.83858951 |
| 89 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.83307489 |
| 90 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.83307489 |
| 91 | myeloid leukocyte activation (GO:0002274) | 2.82491565 |
| 92 | regulation of natural killer cell activation (GO:0032814) | 2.81412252 |
| 93 | regulation of mast cell activation (GO:0033003) | 2.80814157 |
| 94 | regulation of hypersensitivity (GO:0002883) | 2.80479249 |
| 95 | lymph vessel development (GO:0001945) | 2.80065853 |
| 96 | regulation of interferon-alpha production (GO:0032647) | 2.79547686 |
| 97 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.77969390 |
| 98 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.76304024 |
| 99 | regulation of mast cell degranulation (GO:0043304) | 2.75797894 |
| 100 | negative regulation of bone mineralization (GO:0030502) | 2.75617010 |
| 101 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.74339899 |
| 102 | leukocyte aggregation (GO:0070486) | 2.73345986 |
| 103 | Notch signaling involved in heart development (GO:0061314) | 2.72951325 |
| 104 | reactive oxygen species biosynthetic process (GO:1903409) | 2.71964311 |
| 105 | regulation of interleukin-17 production (GO:0032660) | 2.71222030 |
| 106 | central nervous system myelination (GO:0022010) | 2.70975594 |
| 107 | axon ensheathment in central nervous system (GO:0032291) | 2.70975594 |
| 108 | chondroitin sulfate catabolic process (GO:0030207) | 2.70926493 |
| 109 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.70899200 |
| 110 | mannose metabolic process (GO:0006013) | 2.70705668 |
| 111 | positive regulation of vasculogenesis (GO:2001214) | 2.69382538 |
| 112 | mature B cell differentiation (GO:0002335) | 2.68752832 |
| 113 | regulation of B cell differentiation (GO:0045577) | 2.68557122 |
| 114 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.67155327 |
| 115 | regulation of chemokine biosynthetic process (GO:0045073) | 2.67013464 |
| 116 | semaphorin-plexin signaling pathway (GO:0071526) | 2.66478606 |
| 117 | regulation of vasculogenesis (GO:2001212) | 2.64478679 |
| 118 | negative regulation of granulocyte differentiation (GO:0030853) | 2.64416905 |
| 119 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.63307463 |
| 120 | dermatan sulfate metabolic process (GO:0030205) | 2.62626920 |
| 121 | glial cell migration (GO:0008347) | 2.60159844 |
| 122 | oligodendrocyte differentiation (GO:0048709) | 2.59402690 |
| 123 | dermatan sulfate biosynthetic process (GO:0030208) | 2.58212745 |
| 124 | regulation of cholesterol storage (GO:0010885) | 2.54065546 |
| 125 | chondroitin sulfate biosynthetic process (GO:0030206) | 2.53749798 |
| 126 | L-amino acid import (GO:0043092) | 2.52477878 |
| 127 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.50581626 |
| 128 | positive regulation of extracellular matrix organization (GO:1903055) | 2.49723466 |
| 129 | astrocyte differentiation (GO:0048708) | 2.49172025 |
| 130 | regulation of leukocyte degranulation (GO:0043300) | 2.48054757 |
| 131 | cell-cell junction maintenance (GO:0045217) | 2.47641495 |
| 132 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.47447653 |
| 133 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.46497269 |
| 134 | glycosphingolipid catabolic process (GO:0046479) | 2.45686078 |
| 135 | glomerular filtration (GO:0003094) | 2.42925345 |
| 136 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.42820980 |
| 137 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.41567270 |
| 138 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.39686174 |
| 139 | phagocytosis, recognition (GO:0006910) | 2.39163176 |
| 140 | adhesion of symbiont to host cell (GO:0044650) | 2.38758224 |
| 141 | virion attachment to host cell (GO:0019062) | 2.38758224 |
| 142 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.38389842 |
| 143 | regulation of macrophage cytokine production (GO:0010935) | 2.36233619 |
| 144 | positive regulation of receptor recycling (GO:0001921) | 2.35896769 |
| 145 | regulation of synapse structural plasticity (GO:0051823) | 2.34953272 |
| 146 | regulation of ARF GTPase activity (GO:0032312) | 2.34422695 |
| 147 | regulation of early endosome to late endosome transport (GO:2000641) | 2.34261084 |
| 148 | renal filtration (GO:0097205) | 2.34069910 |
| 149 | heart valve formation (GO:0003188) | 2.33197352 |
| 150 | endothelial cell chemotaxis (GO:0035767) | 2.32225931 |
| 151 | positive regulation of protein dephosphorylation (GO:0035307) | 2.31056480 |
| 152 | negative regulation of interleukin-8 production (GO:0032717) | 2.30722724 |
| 153 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.29863357 |
| 154 | amino acid import (GO:0043090) | 2.26670571 |
| 155 | negative regulation of interleukin-12 production (GO:0032695) | 2.26580070 |
| 156 | response to laminar fluid shear stress (GO:0034616) | 2.23066952 |
| 157 | cortical actin cytoskeleton organization (GO:0030866) | 2.21769522 |
| 158 | regulation of macrophage chemotaxis (GO:0010758) | 2.19607211 |
| 159 | astrocyte development (GO:0014002) | 2.19471954 |
| 160 | positive regulation of lipid kinase activity (GO:0090218) | 2.19000056 |
| 161 | cellular extravasation (GO:0045123) | 2.18264590 |
| 162 | cGMP-mediated signaling (GO:0019934) | 2.18024552 |
| 163 | blood vessel maturation (GO:0001955) | 2.16997154 |
| 164 | cortical cytoskeleton organization (GO:0030865) | 2.16816230 |
| 165 | negative regulation of endothelial cell migration (GO:0010596) | 2.16161987 |
| 166 | pinocytosis (GO:0006907) | 2.15956777 |
| 167 | establishment of endothelial barrier (GO:0061028) | 2.15773000 |
| 168 | cellular response to epinephrine stimulus (GO:0071872) | 2.15458686 |
| 169 | protein localization to endosome (GO:0036010) | 2.14758818 |
| 170 | endothelial cell differentiation (GO:0045446) | 2.12586310 |
| 171 | adhesion of symbiont to host (GO:0044406) | 2.11477117 |
| 172 | glycolipid catabolic process (GO:0019377) | 2.10865023 |
| 173 | macrophage activation (GO:0042116) | 2.10555291 |
| 174 | sodium ion export (GO:0071436) | 2.10223656 |
| 175 | basement membrane organization (GO:0071711) | 2.10192255 |
| 176 | cAMP biosynthetic process (GO:0006171) | 2.09939380 |
| 177 | camera-type eye morphogenesis (GO:0048593) | 2.09327055 |
| 178 | apoptotic cell clearance (GO:0043277) | 2.08675311 |
| 179 | actin filament bundle assembly (GO:0051017) | 2.05777280 |
| 180 | actin filament bundle organization (GO:0061572) | 2.05777280 |
| 181 | low-density lipoprotein particle clearance (GO:0034383) | 2.05768614 |
| 182 | white fat cell differentiation (GO:0050872) | 2.04807890 |
| 183 | detection of other organism (GO:0098543) | 2.04309028 |
| 184 | positive regulation of leukocyte degranulation (GO:0043302) | 2.03924304 |
| 185 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.03015511 |
| 186 | positive regulation of vascular permeability (GO:0043117) | 2.02210869 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.18970017 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.60916653 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.51052134 |
| 4 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.26138948 |
| 5 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 4.21504386 |
| 6 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 4.19230300 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.88127001 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.76501791 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.42699194 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.38908553 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.25083161 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.20220376 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.09253292 |
| 14 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.08228303 |
| 15 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.81565572 |
| 16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.78836289 |
| 17 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.68275490 |
| 18 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.64934011 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.60225609 |
| 20 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.59069364 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.51983948 |
| 22 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.49353158 |
| 23 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.44974060 |
| 24 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.44095706 |
| 25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.41618484 |
| 26 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.38001379 |
| 27 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.37662234 |
| 28 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.29022820 |
| 29 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.25357472 |
| 30 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.22710473 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.21252599 |
| 32 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.11800440 |
| 33 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.08012718 |
| 34 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.07283660 |
| 35 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04773141 |
| 36 | MYB_26560356_Chip-Seq_TH2_Human | 1.99172373 |
| 37 | MAF_26560356_Chip-Seq_TH1_Human | 1.96834528 |
| 38 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.93664444 |
| 39 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92668160 |
| 40 | SPI1_23127762_ChIP-Seq_K562_Human | 1.89791246 |
| 41 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.89020799 |
| 42 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.87089671 |
| 43 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.85448685 |
| 44 | KDM2B_26808549_Chip-Seq_K562_Human | 1.85248641 |
| 45 | GATA1_22025678_ChIP-Seq_K562_Human | 1.78456643 |
| 46 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.78020247 |
| 47 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.74820654 |
| 48 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.73754153 |
| 49 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.72805375 |
| 50 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.72331074 |
| 51 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.72323854 |
| 52 | MYB_26560356_Chip-Seq_TH1_Human | 1.66632211 |
| 53 | MYC_22102868_ChIP-Seq_BL_Human | 1.65621730 |
| 54 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.65531189 |
| 55 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.64643609 |
| 56 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.64524704 |
| 57 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.63384381 |
| 58 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.62652309 |
| 59 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.61530147 |
| 60 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.61179192 |
| 61 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.56854154 |
| 62 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.55499499 |
| 63 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.53778727 |
| 64 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.53573147 |
| 65 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.48871688 |
| 66 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.48320223 |
| 67 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.45715292 |
| 68 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.45524804 |
| 69 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.45318951 |
| 70 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45202322 |
| 71 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.43771761 |
| 72 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.41951650 |
| 73 | UTX_26944678_Chip-Seq_JUKART_Human | 1.41552766 |
| 74 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.40339086 |
| 75 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.39857202 |
| 76 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.39212630 |
| 77 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.38336578 |
| 78 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.37851584 |
| 79 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.37419474 |
| 80 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.36280228 |
| 81 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.34720816 |
| 82 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.34188709 |
| 83 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.34188709 |
| 84 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31503159 |
| 85 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.31266950 |
| 86 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.29296375 |
| 87 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.28930256 |
| 88 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.28298356 |
| 89 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.26599813 |
| 90 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.25569085 |
| 91 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.24185350 |
| 92 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.24164021 |
| 93 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.22569664 |
| 94 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.22486182 |
| 95 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.20806770 |
| 96 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20800327 |
| 97 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.20263463 |
| 98 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.19062752 |
| 99 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.17913801 |
| 100 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.17591400 |
| 101 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.17279959 |
| 102 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.16762744 |
| 103 | MAF_26560356_Chip-Seq_TH2_Human | 1.16601351 |
| 104 | P68_20966046_ChIP-Seq_HELA_Human | 1.16530614 |
| 105 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.16468839 |
| 106 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16235792 |
| 107 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16155681 |
| 108 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.13970775 |
| 109 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.13933598 |
| 110 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.13263019 |
| 111 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.12875681 |
| 112 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.12825488 |
| 113 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.12345449 |
| 114 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.11802560 |
| 115 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.11413021 |
| 116 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.10982018 |
| 117 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.10641642 |
| 118 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.10499999 |
| 119 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.10469828 |
| 120 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.10069704 |
| 121 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.09928678 |
| 122 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.09721016 |
| 123 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.08321492 |
| 124 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07868640 |
| 125 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.07849833 |
| 126 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06635572 |
| 127 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.06133363 |
| 128 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.04922614 |
| 129 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.04679606 |
| 130 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.04633994 |
| 131 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03514724 |
| 132 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02363159 |
| 133 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.01952072 |
| 134 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.99974660 |
| 135 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.99960167 |
| 136 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.99901521 |
| 137 | GATA3_26560356_Chip-Seq_TH2_Human | 0.99862796 |
| 138 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.99773417 |
| 139 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99323773 |
| 140 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.99218299 |
| 141 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98693794 |
| 142 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.98376832 |
| 143 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.98055308 |
| 144 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.97854410 |
| 145 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97618183 |
| 146 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97431931 |
| 147 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.96857325 |
| 148 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.96857325 |
| 149 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.96269132 |
| 150 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94986557 |
| 151 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.94637769 |
| 152 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.93660750 |
| 153 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92886751 |
| 154 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.92555696 |
| 155 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.92076376 |
| 156 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90933794 |
| 157 | GATA1_19941826_ChIP-Seq_K562_Human | 0.89653619 |
| 158 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.87812908 |
| 159 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.87735641 |
| 160 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.84214589 |
| 161 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.80884771 |
| 162 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.79539627 |
| 163 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.78053749 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.17789185 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 3.41032435 |
| 3 | MP0003436_decreased_susceptibility_to | 3.32783802 |
| 4 | MP0009785_altered_susceptibility_to | 3.30560794 |
| 5 | MP0000685_abnormal_immune_system | 3.26594751 |
| 6 | MP0010368_abnormal_lymphatic_system | 3.08766688 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 3.05677596 |
| 8 | MP0003724_increased_susceptibility_to | 3.05569518 |
| 9 | MP0002419_abnormal_innate_immunity | 2.84340927 |
| 10 | MP0001545_abnormal_hematopoietic_system | 2.83387168 |
| 11 | MP0005397_hematopoietic_system_phenotyp | 2.83387168 |
| 12 | MP0005464_abnormal_platelet_physiology | 2.79177609 |
| 13 | MP0003303_peritoneal_inflammation | 2.77909993 |
| 14 | MP0005025_abnormal_response_to | 2.75408824 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.62449161 |
| 16 | MP0002396_abnormal_hematopoietic_system | 2.54939968 |
| 17 | MP0002166_altered_tumor_susceptibility | 2.48467153 |
| 18 | MP0003690_abnormal_glial_cell | 2.40224834 |
| 19 | MP0005671_abnormal_response_to | 2.36156658 |
| 20 | MP0004808_abnormal_hematopoietic_stem | 2.35418020 |
| 21 | MP0005174_abnormal_tail_pigmentation | 2.34350502 |
| 22 | MP0002452_abnormal_antigen_presenting | 2.30153931 |
| 23 | MP0004510_myositis | 2.28839156 |
| 24 | MP0001853_heart_inflammation | 2.26702718 |
| 25 | MP0009278_abnormal_bone_marrow | 2.25073656 |
| 26 | MP0002723_abnormal_immune_serum | 2.16648615 |
| 27 | MP0001790_abnormal_immune_system | 2.14230506 |
| 28 | MP0005387_immune_system_phenotype | 2.14230506 |
| 29 | MP0001800_abnormal_humoral_immune | 2.13331089 |
| 30 | MP0001819_abnormal_immune_cell | 2.12132748 |
| 31 | MP0001879_abnormal_lymphatic_vessel | 2.11514960 |
| 32 | MP0002420_abnormal_adaptive_immunity | 2.11377513 |
| 33 | MP0003329_amyloid_beta_deposits | 2.10994079 |
| 34 | MP0002006_tumorigenesis | 2.08459572 |
| 35 | MP0005409_darkened_coat_color | 2.03654271 |
| 36 | MP0001533_abnormal_skeleton_physiology | 1.89579883 |
| 37 | MP0000920_abnormal_myelination | 1.88673754 |
| 38 | MP0002877_abnormal_melanocyte_morpholog | 1.84658983 |
| 39 | MP0002398_abnormal_bone_marrow | 1.84620508 |
| 40 | MP0001348_abnormal_lacrimal_gland | 1.82142500 |
| 41 | MP0000465_gastrointestinal_hemorrhage | 1.81258108 |
| 42 | MP0003183_abnormal_peptide_metabolism | 1.79440395 |
| 43 | MP0002254_reproductive_system_inflammat | 1.78776158 |
| 44 | MP0001849_ear_inflammation | 1.78640368 |
| 45 | MP0000343_altered_response_to | 1.78285520 |
| 46 | MP0000716_abnormal_immune_system | 1.70124433 |
| 47 | MP0005595_abnormal_vascular_smooth | 1.69625287 |
| 48 | MP0010155_abnormal_intestine_physiology | 1.67958514 |
| 49 | MP0002405_respiratory_system_inflammati | 1.67015905 |
| 50 | MP0002653_abnormal_ependyma_morphology | 1.65471074 |
| 51 | MP0003172_abnormal_lysosome_physiology | 1.62454697 |
| 52 | MP0003075_altered_response_to | 1.61454541 |
| 53 | MP0001845_abnormal_inflammatory_respons | 1.60851970 |
| 54 | MP0001873_stomach_inflammation | 1.60710820 |
| 55 | MP0005058_abnormal_lysosome_morphology | 1.59280518 |
| 56 | MP0005666_abnormal_adipose_tissue | 1.57489941 |
| 57 | MP0003300_gastrointestinal_ulcer | 1.57308801 |
| 58 | MP0009764_decreased_sensitivity_to | 1.54247521 |
| 59 | MP0004859_abnormal_synaptic_plasticity | 1.50597587 |
| 60 | MP0004130_abnormal_muscle_cell | 1.49548591 |
| 61 | MP0003634_abnormal_glial_cell | 1.47761337 |
| 62 | MP0002429_abnormal_blood_cell | 1.46984155 |
| 63 | MP0005670_abnormal_white_adipose | 1.46458707 |
| 64 | MP0009333_abnormal_splenocyte_physiolog | 1.45306309 |
| 65 | MP0000689_abnormal_spleen_morphology | 1.44570506 |
| 66 | MP0008469_abnormal_protein_level | 1.43586450 |
| 67 | MP0000490_abnormal_crypts_of | 1.43447765 |
| 68 | MP0004185_abnormal_adipocyte_glucose | 1.42293089 |
| 69 | MP0006082_CNS_inflammation | 1.41402223 |
| 70 | MP0002722_abnormal_immune_system | 1.41008012 |
| 71 | MP0000858_altered_metastatic_potential | 1.40383567 |
| 72 | MP0002163_abnormal_gland_morphology | 1.37833873 |
| 73 | MP0000767_abnormal_smooth_muscle | 1.35259854 |
| 74 | MP0005310_abnormal_salivary_gland | 1.32565458 |
| 75 | MP0004947_skin_inflammation | 1.31763391 |
| 76 | MP0005076_abnormal_cell_differentiation | 1.31288307 |
| 77 | MP0004885_abnormal_endolymph | 1.30366637 |
| 78 | MP0003656_abnormal_erythrocyte_physiolo | 1.23312604 |
| 79 | MP0003186_abnormal_redox_activity | 1.12835295 |
| 80 | MP0003448_altered_tumor_morphology | 1.12581477 |
| 81 | MP0009053_abnormal_anal_canal | 1.11231014 |
| 82 | MP0002095_abnormal_skin_pigmentation | 1.10302151 |
| 83 | MP0002736_abnormal_nociception_after | 1.10017465 |
| 84 | MP0001986_abnormal_taste_sensitivity | 1.09835512 |
| 85 | MP0005023_abnormal_wound_healing | 1.09701870 |
| 86 | MP0010307_abnormal_tumor_latency | 1.09201780 |
| 87 | MP0003279_aneurysm | 1.07431745 |
| 88 | MP0003763_abnormal_thymus_physiology | 1.05430280 |
| 89 | MP0002896_abnormal_bone_mineralization | 1.05133035 |
| 90 | MP0005375_adipose_tissue_phenotype | 1.04793721 |
| 91 | MP0005257_abnormal_intraocular_pressure | 1.04145471 |
| 92 | MP0004883_abnormal_blood_vessel | 1.03825828 |
| 93 | MP0005388_respiratory_system_phenotype | 1.03454803 |
| 94 | MP0002133_abnormal_respiratory_system | 1.03454803 |
| 95 | MP0000569_abnormal_digit_pigmentation | 1.03208666 |
| 96 | MP0004272_abnormal_basement_membrane | 1.02771105 |
| 97 | MP0003866_abnormal_defecation | 1.01497556 |
| 98 | MP0003191_abnormal_cellular_cholesterol | 1.01492338 |
| 99 | MP0005075_abnormal_melanosome_morpholog | 0.98395584 |
| 100 | MP0006054_spinal_hemorrhage | 0.98128537 |
| 101 | MP0002971_abnormal_brown_adipose | 0.98079347 |
| 102 | MP0003453_abnormal_keratinocyte_physiol | 0.96974164 |
| 103 | MP0003566_abnormal_cell_adhesion | 0.96570744 |
| 104 | MP0003136_yellow_coat_color | 0.96178660 |
| 105 | MP0003633_abnormal_nervous_system | 0.95653270 |
| 106 | MP0002998_abnormal_bone_remodeling | 0.95332210 |
| 107 | MP0001663_abnormal_digestive_system | 0.95292918 |
| 108 | MP0004858_abnormal_nervous_system | 0.94973851 |
| 109 | MP0005165_increased_susceptibility_to | 0.94919980 |
| 110 | MP0005166_decreased_susceptibility_to | 0.94676158 |
| 111 | MP0003632_abnormal_nervous_system | 0.94339094 |
| 112 | MP0002249_abnormal_larynx_morphology | 0.94122713 |
| 113 | MP0001958_emphysema | 0.92899155 |
| 114 | MP0002733_abnormal_thermal_nociception | 0.92131249 |
| 115 | MP0000015_abnormal_ear_pigmentation | 0.90439724 |
| 116 | MP0005390_skeleton_phenotype | 0.90320925 |
| 117 | MP0001970_abnormal_pain_threshold | 0.89616473 |
| 118 | MP0005167_abnormal_blood-brain_barrier | 0.88330658 |
| 119 | MP0009379_abnormal_foot_pigmentation | 0.87152309 |
| 120 | MP0005379_endocrine/exocrine_gland_phen | 0.86884885 |
| 121 | MP0000703_abnormal_thymus_morphology | 0.85688289 |
| 122 | MP0009840_abnormal_foam_cell | 0.82567538 |
| 123 | MP0010352_gastrointestinal_tract_polyps | 0.82451422 |
| 124 | MP0003943_abnormal_hepatobiliary_system | 0.81831570 |
| 125 | MP0001851_eye_inflammation | 0.80516969 |
| 126 | MP0003631_nervous_system_phenotype | 0.80361650 |
| 127 | MP0006138_congestive_heart_failure | 0.80249424 |
| 128 | MP0005164_abnormal_response_to | 0.80236633 |
| 129 | MP0009115_abnormal_fat_cell | 0.80014799 |
| 130 | MP0001614_abnormal_blood_vessel | 0.78708473 |
| 131 | MP0001486_abnormal_startle_reflex | 0.78636848 |
| 132 | MP0000778_abnormal_nervous_system | 0.78049486 |
| 133 | MP0000249_abnormal_blood_vessel | 0.77877933 |
| 134 | MP0005508_abnormal_skeleton_morphology | 0.77382945 |
| 135 | MP0009763_increased_sensitivity_to | 0.75867725 |
| 136 | MP0003828_pulmonary_edema | 0.75735226 |
| 137 | MP0003638_abnormal_response/metabolism_ | 0.73858595 |
| 138 | MP0002009_preneoplasia | 0.73699326 |
| 139 | MP0001968_abnormal_touch/_nociception | 0.70396036 |
| 140 | MP0003045_fibrosis | 0.70154941 |
| 141 | MP0000371_diluted_coat_color | 0.70008294 |
| 142 | MP0003091_abnormal_cell_migration | 0.69243731 |
| 143 | MP0000026_abnormal_inner_ear | 0.69228301 |
| 144 | MP0002933_joint_inflammation | 0.68067348 |
| 145 | MP0008260_abnormal_autophagy | 0.66781922 |
| 146 | MP0003283_abnormal_digestive_organ | 0.63890258 |
| 147 | MP0002064_seizures | 0.63843628 |
| 148 | MP0002019_abnormal_tumor_incidence | 0.62828830 |
| 149 | MP0008874_decreased_physiological_sensi | 0.62621918 |
| 150 | MP0002138_abnormal_hepatobiliary_system | 0.60063443 |
| 151 | MP0001502_abnormal_circadian_rhythm | 0.59274919 |
| 152 | MP0000604_amyloidosis | 0.58680975 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.47300802 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.96868420 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.96498769 |
| 4 | Myositis (HP:0100614) | 4.59267258 |
| 5 | Thrombocytosis (HP:0001894) | 4.51018574 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.44908185 |
| 7 | Chronic otitis media (HP:0000389) | 4.13234471 |
| 8 | Mediastinal lymphadenopathy (HP:0100721) | 4.03611830 |
| 9 | Prolonged bleeding time (HP:0003010) | 3.95058649 |
| 10 | Petechiae (HP:0000967) | 3.94602068 |
| 11 | Abnormality of macrophages (HP:0004311) | 3.93196238 |
| 12 | Orchitis (HP:0100796) | 3.87765248 |
| 13 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.84781466 |
| 14 | Recurrent fungal infections (HP:0002841) | 3.61123608 |
| 15 | Systemic lupus erythematosus (HP:0002725) | 3.53867059 |
| 16 | Neurofibrillary tangles (HP:0002185) | 3.42967817 |
| 17 | Chronic obstructive pulmonary disease (HP:0006510) | 3.42625443 |
| 18 | Obstructive lung disease (HP:0006536) | 3.42625443 |
| 19 | Optic neuritis (HP:0100653) | 3.38515344 |
| 20 | Retrobulbar optic neuritis (HP:0100654) | 3.38515344 |
| 21 | Recurrent skin infections (HP:0001581) | 3.35984978 |
| 22 | Cellulitis (HP:0100658) | 3.30268365 |
| 23 | Impaired platelet aggregation (HP:0003540) | 3.16111757 |
| 24 | Abnormal platelet function (HP:0011869) | 3.16111757 |
| 25 | Increased cerebral lipofuscin (HP:0011813) | 3.14092810 |
| 26 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.12535570 |
| 27 | Epistaxis (HP:0000421) | 3.06064569 |
| 28 | Interstitial pulmonary disease (HP:0006530) | 2.98200815 |
| 29 | Nasal polyposis (HP:0100582) | 2.97780875 |
| 30 | Obstructive sleep apnea (HP:0002870) | 2.97079545 |
| 31 | Abnormality of the nasal mucosa (HP:0000433) | 2.96985818 |
| 32 | Loss of speech (HP:0002371) | 2.93865485 |
| 33 | Abnormal number of erythroid precursors (HP:0012131) | 2.91926893 |
| 34 | Recurrent viral infections (HP:0004429) | 2.90960223 |
| 35 | Periodontitis (HP:0000704) | 2.90709729 |
| 36 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.88350925 |
| 37 | Vertebral compression fractures (HP:0002953) | 2.86079497 |
| 38 | Autoimmune thrombocytopenia (HP:0001973) | 2.78873289 |
| 39 | Arterial thrombosis (HP:0004420) | 2.78528142 |
| 40 | Meningitis (HP:0001287) | 2.75447546 |
| 41 | Gingival bleeding (HP:0000225) | 2.74937496 |
| 42 | J-shaped sella turcica (HP:0002680) | 2.71294680 |
| 43 | Purpura (HP:0000979) | 2.71080932 |
| 44 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.69091834 |
| 45 | Recurrent cutaneous fungal infections (HP:0011370) | 2.69091834 |
| 46 | Cerebral aneurysm (HP:0004944) | 2.65211260 |
| 47 | Hemiplegia (HP:0002301) | 2.64888047 |
| 48 | Gingivitis (HP:0000230) | 2.64058171 |
| 49 | Vasculitis (HP:0002633) | 2.62611872 |
| 50 | Nuclear cataract (HP:0100018) | 2.60808687 |
| 51 | Vacuolated lymphocytes (HP:0001922) | 2.57620157 |
| 52 | Protrusio acetabuli (HP:0003179) | 2.57179006 |
| 53 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.54787295 |
| 54 | Deformed sella turcica (HP:0002681) | 2.54431837 |
| 55 | Thoracic kyphosis (HP:0002942) | 2.52893905 |
| 56 | Mucopolysacchariduria (HP:0008155) | 2.51882822 |
| 57 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.51882822 |
| 58 | Action tremor (HP:0002345) | 2.50717749 |
| 59 | Aplastic anemia (HP:0001915) | 2.50654507 |
| 60 | Recurrent bronchitis (HP:0002837) | 2.48798083 |
| 61 | Urticaria (HP:0001025) | 2.47655031 |
| 62 | Abnormality of the lumbar spine (HP:0100712) | 2.47049792 |
| 63 | Beaking of vertebral bodies (HP:0004568) | 2.46539963 |
| 64 | Abnormal platelet volume (HP:0011876) | 2.45233741 |
| 65 | Cerebral inclusion bodies (HP:0100314) | 2.45145425 |
| 66 | Reduced antithrombin III activity (HP:0001976) | 2.43220591 |
| 67 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.43011958 |
| 68 | Hyperacusis (HP:0010780) | 2.40083454 |
| 69 | Turricephaly (HP:0000262) | 2.39905732 |
| 70 | Albinism (HP:0001022) | 2.39626730 |
| 71 | Pulmonary infiltrates (HP:0002113) | 2.38759541 |
| 72 | Axonal loss (HP:0003447) | 2.34559039 |
| 73 | Mutism (HP:0002300) | 2.33927347 |
| 74 | Hemorrhage of the eye (HP:0011885) | 2.33414935 |
| 75 | Dysostosis multiplex (HP:0000943) | 2.31462022 |
| 76 | Acute myeloid leukemia (HP:0004808) | 2.27149975 |
| 77 | Chest pain (HP:0100749) | 2.27123982 |
| 78 | Arterial tortuosity (HP:0005116) | 2.26726685 |
| 79 | Stomatitis (HP:0010280) | 2.25946575 |
| 80 | Polygenic inheritance (HP:0010982) | 2.25691028 |
| 81 | Abnormality of binocular vision (HP:0011514) | 2.25587492 |
| 82 | Diplopia (HP:0000651) | 2.25587492 |
| 83 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.24129502 |
| 84 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.24129502 |
| 85 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.24129502 |
| 86 | Mitral regurgitation (HP:0001653) | 2.24011422 |
| 87 | Abnormality of the thoracic spine (HP:0100711) | 2.23313489 |
| 88 | Basal ganglia calcification (HP:0002135) | 2.22882327 |
| 89 | Hypergammaglobulinemia (HP:0010702) | 2.22762995 |
| 90 | Leukocytosis (HP:0001974) | 2.20957547 |
| 91 | Increased IgE level (HP:0003212) | 2.20754400 |
| 92 | Menorrhagia (HP:0000132) | 2.19066118 |
| 93 | Broad metatarsal (HP:0001783) | 2.19002751 |
| 94 | IgM deficiency (HP:0002850) | 2.18151977 |
| 95 | Abnormality of glycolipid metabolism (HP:0010969) | 2.15840110 |
| 96 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.15840110 |
| 97 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.15840110 |
| 98 | Papilledema (HP:0001085) | 2.15662781 |
| 99 | Neoplasm of head and neck (HP:0012288) | 2.14682144 |
| 100 | Esophageal neoplasm (HP:0100751) | 2.14682144 |
| 101 | Vascular tortuosity (HP:0004948) | 2.14179318 |
| 102 | Neuronal loss in central nervous system (HP:0002529) | 2.12991786 |
| 103 | Increased mean platelet volume (HP:0011877) | 2.11761912 |
| 104 | Peritonitis (HP:0002586) | 2.10622333 |
| 105 | Spinal cord lesions (HP:0100561) | 2.10260934 |
| 106 | Syringomyelia (HP:0003396) | 2.10260934 |
| 107 | Hemoptysis (HP:0002105) | 2.09779027 |
| 108 | Annular pancreas (HP:0001734) | 2.08507372 |
| 109 | Ulnar bowing (HP:0003031) | 2.08256302 |
| 110 | Shallow orbits (HP:0000586) | 2.08078445 |
| 111 | Keratoconjunctivitis (HP:0001096) | 2.07193311 |
| 112 | Apathy (HP:0000741) | 2.06276044 |
| 113 | Increased variability in muscle fiber diameter (HP:0003557) | 2.03784258 |
| 114 | Increased serum ferritin (HP:0003281) | 2.02443730 |
| 115 | Hematochezia (HP:0002573) | 2.02024341 |
| 116 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.01559940 |
| 117 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.00806251 |
| 118 | Abnormality of T cell physiology (HP:0011840) | 2.00676782 |
| 119 | Biconcave vertebral bodies (HP:0004586) | 1.99775889 |
| 120 | Abnormality of the prostate (HP:0008775) | 1.99646226 |
| 121 | Bruising susceptibility (HP:0000978) | 1.99570374 |
| 122 | Myocardial infarction (HP:0001658) | 1.99295485 |
| 123 | Cervical subluxation (HP:0003308) | 1.99028280 |
| 124 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.98909719 |
| 125 | Onion bulb formation (HP:0003383) | 1.97708733 |
| 126 | Broad face (HP:0000283) | 1.97417511 |
| 127 | Osteomyelitis (HP:0002754) | 1.96476449 |
| 128 | Glomerulonephritis (HP:0000099) | 1.96453183 |
| 129 | Esophageal varix (HP:0002040) | 1.95588222 |
| 130 | Conjunctival telangiectasia (HP:0000524) | 1.95393652 |
| 131 | Spontaneous hematomas (HP:0007420) | 1.95091509 |
| 132 | Recurrent pneumonia (HP:0006532) | 1.94525905 |
| 133 | Diminished motivation (HP:0000745) | 1.94162711 |
| 134 | Thin bony cortex (HP:0002753) | 1.93828911 |
| 135 | Keratoconjunctivitis sicca (HP:0001097) | 1.93822454 |
| 136 | Amyloidosis (HP:0011034) | 1.91884948 |
| 137 | Tetraparesis (HP:0002273) | 1.90132775 |
| 138 | Radial bowing (HP:0002986) | 1.88580063 |
| 139 | Supranuclear gaze palsy (HP:0000605) | 1.88487367 |
| 140 | Polycythemia (HP:0001901) | 1.87511255 |
| 141 | Abnormality of the diencephalon (HP:0010662) | 1.86852363 |
| 142 | Disinhibition (HP:0000734) | 1.86249870 |
| 143 | Bronchomalacia (HP:0002780) | 1.83198221 |
| 144 | Abnormal eating behavior (HP:0100738) | 1.79874893 |
| 145 | Insomnia (HP:0100785) | 1.79813666 |
| 146 | Rapidly progressive (HP:0003678) | 1.75004851 |
| 147 | Abnormality of the periventricular white matter (HP:0002518) | 1.73230345 |
| 148 | Hypertriglyceridemia (HP:0002155) | 1.71780541 |
| 149 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.71019557 |
| 150 | Short 4th metacarpal (HP:0010044) | 1.71019557 |
| 151 | Genu recurvatum (HP:0002816) | 1.70008608 |
| 152 | Hyperparathyroidism (HP:0000843) | 1.69748389 |
| 153 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.69376038 |
| 154 | Neonatal short-limb short stature (HP:0008921) | 1.69299869 |
| 155 | Dementia (HP:0000726) | 1.68538523 |
| 156 | Abnormality of the 4th metacarpal (HP:0010012) | 1.67567116 |
| 157 | Abnormal vertebral ossification (HP:0100569) | 1.65544039 |
| 158 | Visceral angiomatosis (HP:0100761) | 1.64705189 |
| 159 | Disproportionate tall stature (HP:0001519) | 1.63975551 |
| 160 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.62121197 |
| 161 | Pulmonary artery stenosis (HP:0004415) | 1.61836191 |
| 162 | Tibial bowing (HP:0002982) | 1.60154405 |
| 163 | Mesangial abnormality (HP:0001966) | 1.60056614 |
| 164 | Pulmonary hypertension (HP:0002092) | 1.58977467 |
| 165 | Abnormality of complement system (HP:0005339) | 1.58214867 |
| 166 | Premature rupture of membranes (HP:0001788) | 1.56923276 |
| 167 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.54565095 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHB2 | 3.78259602 |
| 2 | KIT | 3.43129722 |
| 3 | IRAK4 | 3.08031185 |
| 4 | MAP3K14 | 2.83538261 |
| 5 | PIM2 | 2.71062406 |
| 6 | MAP3K12 | 2.64791935 |
| 7 | TBK1 | 2.57953616 |
| 8 | MUSK | 2.41447079 |
| 9 | RIPK4 | 2.35450812 |
| 10 | NME2 | 2.30118759 |
| 11 | MAP4K1 | 2.25797079 |
| 12 | MAPK15 | 2.23824196 |
| 13 | IKBKB | 2.21242492 |
| 14 | MATK | 2.20688790 |
| 15 | JAK3 | 2.09138250 |
| 16 | PRPF4B | 2.04573338 |
| 17 | TYK2 | 2.03050714 |
| 18 | IKBKE | 2.01899833 |
| 19 | BTK | 1.98730157 |
| 20 | PRKD3 | 1.96832896 |
| 21 | TEC | 1.84011641 |
| 22 | FES | 1.83820434 |
| 23 | NTRK1 | 1.81301429 |
| 24 | BLK | 1.81153706 |
| 25 | EEF2K | 1.79434020 |
| 26 | TYRO3 | 1.78128022 |
| 27 | MAP3K3 | 1.55061113 |
| 28 | TGFBR1 | 1.52206745 |
| 29 | IRAK3 | 1.49838585 |
| 30 | EPHB1 | 1.49407301 |
| 31 | SYK | 1.48326242 |
| 32 | MARK2 | 1.47277848 |
| 33 | TRPM7 | 1.45481715 |
| 34 | FLT3 | 1.44105695 |
| 35 | LRRK2 | 1.42538949 |
| 36 | TRIB3 | 1.41281260 |
| 37 | MAP3K13 | 1.39688694 |
| 38 | MAP3K11 | 1.36864304 |
| 39 | PIM1 | 1.36469303 |
| 40 | CSF1R | 1.35238305 |
| 41 | PDGFRA | 1.35168382 |
| 42 | TAOK1 | 1.35113557 |
| 43 | ERN1 | 1.34565336 |
| 44 | PRKG2 | 1.33689132 |
| 45 | NTRK3 | 1.30852587 |
| 46 | NTRK2 | 1.28837314 |
| 47 | DDR2 | 1.27691947 |
| 48 | JAK1 | 1.25024652 |
| 49 | PTK2 | 1.24967390 |
| 50 | EIF2AK3 | 1.22580423 |
| 51 | SIK1 | 1.22015473 |
| 52 | MAPKAPK5 | 1.21705152 |
| 53 | CHUK | 1.19760739 |
| 54 | ZAP70 | 1.16019936 |
| 55 | MAP2K3 | 1.13212014 |
| 56 | KSR2 | 1.12462859 |
| 57 | CAMKK2 | 1.11458036 |
| 58 | TNIK | 1.10160686 |
| 59 | ICK | 1.09663446 |
| 60 | TAOK3 | 1.09141646 |
| 61 | PTK2B | 1.08543852 |
| 62 | TNK2 | 1.06365023 |
| 63 | PAK6 | 1.06330182 |
| 64 | CDC42BPA | 1.05623558 |
| 65 | PRKD2 | 1.02701655 |
| 66 | TGFBR2 | 1.01370885 |
| 67 | SMG1 | 1.00510160 |
| 68 | HCK | 1.00191367 |
| 69 | LYN | 0.98995121 |
| 70 | FGR | 0.97649806 |
| 71 | GRK6 | 0.97637951 |
| 72 | EIF2AK2 | 0.94696536 |
| 73 | PDGFRB | 0.92887231 |
| 74 | PDPK1 | 0.92638645 |
| 75 | TXK | 0.92215558 |
| 76 | FGFR3 | 0.91411993 |
| 77 | NEK9 | 0.90411415 |
| 78 | PAK4 | 0.88661039 |
| 79 | STK16 | 0.88645674 |
| 80 | RPS6KA4 | 0.86494961 |
| 81 | SCYL2 | 0.85990811 |
| 82 | JAK2 | 0.85580242 |
| 83 | DMPK | 0.85350441 |
| 84 | LATS2 | 0.84687616 |
| 85 | CAMK1D | 0.84664841 |
| 86 | LCK | 0.84021570 |
| 87 | TIE1 | 0.82821891 |
| 88 | TESK2 | 0.82541236 |
| 89 | NLK | 0.80017095 |
| 90 | ROCK2 | 0.79972541 |
| 91 | MARK1 | 0.77628550 |
| 92 | MAPKAPK3 | 0.77028902 |
| 93 | CDK8 | 0.76176282 |
| 94 | PKN2 | 0.75983061 |
| 95 | EPHA3 | 0.75902465 |
| 96 | MKNK1 | 0.75469988 |
| 97 | MAPK4 | 0.74205748 |
| 98 | CAMK1G | 0.73791405 |
| 99 | PKN1 | 0.69510350 |
| 100 | ABL2 | 0.68887839 |
| 101 | KSR1 | 0.68401224 |
| 102 | CDK19 | 0.66689907 |
| 103 | DAPK1 | 0.66228545 |
| 104 | PTK6 | 0.65649346 |
| 105 | MAP3K6 | 0.65472028 |
| 106 | ILK | 0.65467836 |
| 107 | ROCK1 | 0.65169236 |
| 108 | TAOK2 | 0.64769509 |
| 109 | RIPK1 | 0.62336820 |
| 110 | MYLK | 0.59564705 |
| 111 | FER | 0.59406528 |
| 112 | RPS6KA6 | 0.59394519 |
| 113 | CAMK2B | 0.59095128 |
| 114 | SGK3 | 0.56948514 |
| 115 | MOS | 0.56895058 |
| 116 | PRKCD | 0.56103691 |
| 117 | MAPK7 | 0.55760329 |
| 118 | PRKD1 | 0.55309372 |
| 119 | ARAF | 0.54778887 |
| 120 | KDR | 0.54662238 |
| 121 | CSK | 0.53976711 |
| 122 | TESK1 | 0.53800051 |
| 123 | IRAK2 | 0.53792621 |
| 124 | MAPK12 | 0.52900089 |
| 125 | RPS6KA2 | 0.52897086 |
| 126 | BMX | 0.52634421 |
| 127 | SIK2 | 0.52382058 |
| 128 | MAPKAPK2 | 0.51859016 |
| 129 | RET | 0.49826145 |
| 130 | MTOR | 0.49815369 |
| 131 | GSK3A | 0.49355395 |
| 132 | CDK6 | 0.47746423 |
| 133 | PNCK | 0.47356331 |
| 134 | IRAK1 | 0.47310967 |
| 135 | RPS6KB2 | 0.47103934 |
| 136 | FYN | 0.46942181 |
| 137 | SRC | 0.46225361 |
| 138 | CAMKK1 | 0.43915854 |
| 139 | RPS6KC1 | 0.43644571 |
| 140 | RPS6KL1 | 0.43644571 |
| 141 | HIPK2 | 0.43324902 |
| 142 | YES1 | 0.43193575 |
| 143 | MAP3K8 | 0.42936842 |
| 144 | MAP2K1 | 0.42498147 |
| 145 | SGK223 | 0.42211896 |
| 146 | SGK494 | 0.42211896 |
| 147 | PIK3CG | 0.42012107 |
| 148 | LMTK2 | 0.41758440 |
| 149 | RPS6KB1 | 0.40141616 |
| 150 | MAP3K1 | 0.39496890 |
| 151 | WEE1 | 0.39494834 |
| 152 | BRSK2 | 0.39039923 |
| 153 | ABL1 | 0.38193827 |
| 154 | VRK1 | 0.37308720 |
| 155 | MAP2K6 | 0.36732827 |
| 156 | ALK | 0.34455573 |
| 157 | STK10 | 0.33966769 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.27232893 |
| 2 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.31189821 |
| 3 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.30095354 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.29864908 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.19410769 |
| 6 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.18768352 |
| 7 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.13879626 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.09841417 |
| 9 | Pertussis_Homo sapiens_hsa05133 | 2.03897285 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.00283097 |
| 11 | Asthma_Homo sapiens_hsa05310 | 1.92841387 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.92112167 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.89561495 |
| 14 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.88982115 |
| 15 | Malaria_Homo sapiens_hsa05144 | 1.88427377 |
| 16 | Legionellosis_Homo sapiens_hsa05134 | 1.82681375 |
| 17 | Allograft rejection_Homo sapiens_hsa05330 | 1.82288924 |
| 18 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.79767624 |
| 19 | Tuberculosis_Homo sapiens_hsa05152 | 1.78982053 |
| 20 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.77528480 |
| 21 | DNA replication_Homo sapiens_hsa03030 | 1.74283910 |
| 22 | Ribosome_Homo sapiens_hsa03010 | 1.73435582 |
| 23 | Shigellosis_Homo sapiens_hsa05131 | 1.70007339 |
| 24 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.66439147 |
| 25 | Salmonella infection_Homo sapiens_hsa05132 | 1.65027753 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.64028580 |
| 27 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.62847873 |
| 28 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.60593615 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.57590983 |
| 30 | Apoptosis_Homo sapiens_hsa04210 | 1.56807348 |
| 31 | Prion diseases_Homo sapiens_hsa05020 | 1.53749512 |
| 32 | Platelet activation_Homo sapiens_hsa04611 | 1.53064900 |
| 33 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.52205822 |
| 34 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.48209932 |
| 35 | Influenza A_Homo sapiens_hsa05164 | 1.44205662 |
| 36 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.42910369 |
| 37 | Hepatitis B_Homo sapiens_hsa05161 | 1.38449635 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.38302191 |
| 39 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.36959816 |
| 40 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.35932084 |
| 41 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.34163711 |
| 42 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.33246506 |
| 43 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.32834738 |
| 44 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.32341908 |
| 45 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.26184612 |
| 46 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.23728716 |
| 47 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.20549724 |
| 48 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.19202941 |
| 49 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.17791589 |
| 50 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.17394417 |
| 51 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.15128348 |
| 52 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.14114003 |
| 53 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.13854601 |
| 54 | Phagosome_Homo sapiens_hsa04145 | 1.07035580 |
| 55 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.07026082 |
| 56 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.06829104 |
| 57 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.06828441 |
| 58 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.05048344 |
| 59 | Other glycan degradation_Homo sapiens_hsa00511 | 1.04703879 |
| 60 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.02794394 |
| 61 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.02604516 |
| 62 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.02429988 |
| 63 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.01705481 |
| 64 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.01686069 |
| 65 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.01196955 |
| 66 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.00594686 |
| 67 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.99511879 |
| 68 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.99384743 |
| 69 | Lysosome_Homo sapiens_hsa04142 | 0.97090653 |
| 70 | Endocytosis_Homo sapiens_hsa04144 | 0.95511587 |
| 71 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.91114866 |
| 72 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.86731356 |
| 73 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.86014532 |
| 74 | Axon guidance_Homo sapiens_hsa04360 | 0.84980883 |
| 75 | Cocaine addiction_Homo sapiens_hsa05030 | 0.84629159 |
| 76 | Viral myocarditis_Homo sapiens_hsa05416 | 0.84296619 |
| 77 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.83091065 |
| 78 | Hepatitis C_Homo sapiens_hsa05160 | 0.82831222 |
| 79 | Histidine metabolism_Homo sapiens_hsa00340 | 0.82785115 |
| 80 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.82427567 |
| 81 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.80603335 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.80539771 |
| 83 | Morphine addiction_Homo sapiens_hsa05032 | 0.80231110 |
| 84 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.79429853 |
| 85 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.78710984 |
| 86 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.76088338 |
| 87 | Adherens junction_Homo sapiens_hsa04520 | 0.75718949 |
| 88 | Renin secretion_Homo sapiens_hsa04924 | 0.75462308 |
| 89 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.75171247 |
| 90 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.74579110 |
| 91 | Bladder cancer_Homo sapiens_hsa05219 | 0.74534720 |
| 92 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.74512377 |
| 93 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.74166634 |
| 94 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.72551868 |
| 95 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.71374242 |
| 96 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.70638254 |
| 97 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.68598667 |
| 98 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.67695381 |
| 99 | Circadian entrainment_Homo sapiens_hsa04713 | 0.67676989 |
| 100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67243428 |
| 101 | Gap junction_Homo sapiens_hsa04540 | 0.66084187 |
| 102 | Amoebiasis_Homo sapiens_hsa05146 | 0.66058479 |
| 103 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.65965088 |
| 104 | Bile secretion_Homo sapiens_hsa04976 | 0.65907535 |
| 105 | Base excision repair_Homo sapiens_hsa03410 | 0.65856805 |
| 106 | Colorectal cancer_Homo sapiens_hsa05210 | 0.65154091 |
| 107 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.63102315 |
| 108 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.62785527 |
| 109 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62767202 |
| 110 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.62761143 |
| 111 | Endometrial cancer_Homo sapiens_hsa05213 | 0.62063180 |
| 112 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.61182158 |
| 113 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.60370107 |
| 114 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.60049723 |
| 115 | Long-term potentiation_Homo sapiens_hsa04720 | 0.59983724 |
| 116 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59889878 |
| 117 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.59421194 |
| 118 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.59210291 |
| 119 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.55595915 |
| 120 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.55297406 |
| 121 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.54184295 |
| 122 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.53393262 |
| 123 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.52754478 |
| 124 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.52479384 |
| 125 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.51169246 |
| 126 | Pathways in cancer_Homo sapiens_hsa05200 | 0.50569371 |
| 127 | Melanogenesis_Homo sapiens_hsa04916 | 0.50096640 |
| 128 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.49628291 |
| 129 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.48759180 |
| 130 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.48105752 |
| 131 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.47515457 |
| 132 | Galactose metabolism_Homo sapiens_hsa00052 | 0.46472553 |
| 133 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44524789 |
| 134 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.41925485 |
| 135 | HTLV-I infection_Homo sapiens_hsa05166 | 0.41592467 |
| 136 | Glioma_Homo sapiens_hsa05214 | 0.41324367 |
| 137 | Thyroid cancer_Homo sapiens_hsa05216 | 0.40922127 |
| 138 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.37672519 |
| 139 | Homologous recombination_Homo sapiens_hsa03440 | 0.36753031 |
| 140 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.35978362 |
| 141 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.35463108 |
| 142 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35409610 |
| 143 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.34382980 |
| 144 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.28000441 |
| 145 | Focal adhesion_Homo sapiens_hsa04510 | 0.27177227 |
| 146 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.27018296 |
| 147 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.25747840 |
| 148 | Melanoma_Homo sapiens_hsa05218 | 0.25270437 |
| 149 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.25191584 |

